Pre-Eclampsia

"Pre-Eclampsia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Descriptor ID	D011225
MeSH Number(s)	C13.703.395.249
Concept/Terms	Pre-Eclampsia Pre-Eclampsia Pre Eclampsia Preeclampsia Pregnancy Toxemias Pregnancy Toxemia Toxemia, Pregnancy Edema-Proteinuria-Hypertension Gestosis Edema Proteinuria Hypertension Gestosis Gestosis, Edema-Proteinuria-Hypertension Hypertension-Edema-Proteinuria Gestosis Gestosis, Hypertension-Edema-Proteinuria Hypertension Edema Proteinuria Gestosis Toxemia Of Pregnancy Of Pregnancies, Toxemia Of Pregnancy, Toxemia Pregnancies, Toxemia Of Pregnancy, Toxemia Of Toxemia Of Pregnancies EPH Complex EPH Toxemias EPH Toxemia Toxemia, EPH Toxemias, EPH EPH Gestosis Gestosis, EPH Toxemias, Pregnancy Preeclampsia Eclampsia 1 1, Preeclampsia Eclampsia 1s, Preeclampsia Eclampsia Eclampsia 1, Preeclampsia Eclampsia 1s, Preeclampsia Preeclampsia Eclampsia 1s Proteinuria-Edema-Hypertension Gestosis Gestosis, Proteinuria-Edema-Hypertension Proteinuria Edema Hypertension Gestosis

Below are MeSH descriptors whose meaning is more general than "Pre-Eclampsia".

Diseases [C]
Female Urogenital Diseases and Pregnancy Complications [C13]
Pregnancy Complications [C13.703]
Hypertension, Pregnancy-Induced [C13.703.395]
Pre-Eclampsia [C13.703.395.249]

Below are MeSH descriptors whose meaning is related to "Pre-Eclampsia".

Below are MeSH descriptors whose meaning is more specific than "Pre-Eclampsia".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pre-Eclampsia" by people in this website by year, and whether "Pre-Eclampsia" was a major or minor topic of these publications.

Bar chart showing 121 publications over 26 distinct years, with a maximum of 15 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	1	2
1998	1	0	1
1999	1	0	1
2000	0	1	1
2002	1	1	2
2003	0	2	2
2005	2	0	2
2007	3	0	3
2008	2	1	3
2009	1	1	2
2010	2	1	3
2011	2	1	3
2012	2	1	3
2013	5	1	6
2014	7	2	9
2015	6	3	9
2016	7	3	10
2017	5	1	6
2018	7	0	7
2019	1	3	4
2020	10	0	10
2021	5	0	5
2022	6	0	6
2023	15	0	15
2024	2	3	5

Below are the most recent publications written about "Pre-Eclampsia" by people in Profiles.

Quist-Nelson J, de Ruigh A, Lemoine ER, Pajkrt E, Mol B, Vigil-De Gracia P, Ludmir J, Askie L, Berghella V. Early magnesium discontinuation postpartum and eclampsia risk: A systematic review and meta-analysis. Pregnancy Hypertens. 2024 Sep; 37:101141.

View in: PubMed
Ayyash MK, McLaren R, Shaman M, Al-Kouatly HB. Trends in Preeclampsia Risk Factors in the US From 2010 to 2021. JAMA. 2024 07 09; 332(2):167-169.

View in: PubMed
Sanusi AA, Leach J, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson KS, Haas DM, Plante L, Metz TD, Casey B, Esplin S, Longo S, Hoffman MK, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Su EJ, Krishna I, Nguyen NA, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Kuo HC, Sinkey RG, Librizzi R, Pereira L, Magann EF, Habli M, Williams S, Mari G, Pridjian G, McKenna DS, Parrish M, Osmundson S, Quinones J, Szychowski JM, Tita ATN. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024 Jul 01; 144(1):126-134.

View in: PubMed
Mogos MF, Ahn S, Park C, LaNoue M, Osmundson S, Muchira JM. Twenty-Four-Hour Ambulatory Blood Pressure Monitoring Parameters During Pregnancy: A Pilot Study. J Womens Health (Larchmt). 2024 Jun; 33(6):788-797.

View in: PubMed
Hoffman MK. Aspirin in Pregnancy. Obstet Gynecol. 2024 Mar 01; 143(3):e88.

View in: PubMed
Boelig RC, Kaushal G, Rochani A, McKenzie SE, Kraft WK. Aspirin pharmacokinetics and pharmacodynamics through gestation. Am J Obstet Gynecol. 2024 Sep; 231(3):344.e1-344.e16.

View in: PubMed
Early ML, Raja M, Luo A, Solow M, Matusiak K, Eke AC, Shehata N, Kuo KHM, Lanzkron S, Malinowski AK, Pecker LH. Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease. Br J Haematol. 2024 03; 204(3):1039-1046.

View in: PubMed
Critchlow E, Wodoslawsky S, Makhamreh MM, Rice SM, Turan OM, Firman B, McLaren R, Araji S, Al-Kouatly HB. Maternal outcomes of a cohort of pregnancies affected by non-immune hydrops fetalis. Int J Gynaecol Obstet. 2024 Apr; 165(1):318-327.

View in: PubMed
Nuss EE, Hoffman MK. Reply to: Is it possible for prevention of preterm birth with aspirin? Am J Obstet Gynecol MFM. 2023 12; 5(12):101205.

View in: PubMed
Early ML, Luo A, Solow M, Matusiak K, Eke AC, Shehata N, August P, Kuo KHM, Lanzkron S, Malinowski AK, Pecker LH. Natural history of blood pressure in sickle cell disease pregnancy. Br J Haematol. 2024 02; 204(2):658-667.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement